These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19938108)

  • 1. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation.
    Asaoka T; Kato T; Marubashi S; Dono K; Hama N; Takahashi H; Kobayashi S; Takeda Y; Takemasa I; Nagano H; Yoshida H; Ruiz P; Tzakis AG; Matsubara K; Monden M; Doki Y; Mori M
    Liver Transpl; 2009 Dec; 15(12):1738-49. PubMed ID: 19938108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Rasmussen DL; Wiesner RH; Charlton MR
    Liver Transpl; 2002 Sep; 8(9):814-21. PubMed ID: 12200784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation.
    Regev A; Molina E; Moura R; Bejarano PA; Khaled A; Ruiz P; Arheart K; Berho M; Drachenberg CB; Mendez P; O'Brien C; Jeffers L; Tzakis A; Schiff ER
    Liver Transpl; 2004 Oct; 10(10):1233-9. PubMed ID: 15376303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation.
    Joshi D; Salehi S; Brereton H; Arno M; Quaglia A; Heaton N; O'Grady J; Agarwal K; Aluvihare V
    Liver Transpl; 2013 Apr; 19(4):383-94. PubMed ID: 23408392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ischemic preconditioning on the genomic response to reperfusion injury in deceased donor liver transplantation.
    Jassem W; Fuggle S; Thompson R; Arno M; Taylor J; Byrne J; Heaton N; Rela M
    Liver Transpl; 2009 Dec; 15(12):1750-65. PubMed ID: 19938126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL
    Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.
    Jain A; Ryan C; Mohanka R; Orloff M; Abt P; Romano J; Bryan L; Batzold P; Mantry P; Bozorgzadeh A
    Clin Transplant; 2006; 20(5):624-33. PubMed ID: 16968489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of gene expression profile in liver transplant recipients with hepatitis C virus.
    Muffak-Granero K; Bueno P; Olmedo C; Comino AM; Hassan L; Garcia-Alcalde F; Serradilla M; García-Navarro A; Mansilla A; Villar JM; Garrote D; Blanco A; Ferrón JA
    Transplant Proc; 2008 Nov; 40(9):2971-4. PubMed ID: 19010163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood eosinophilia after living donor liver transplantation for hepatitis C virus-related cirrhosis.
    Kishi Y; Sugawara Y; Kaneko J; Tamura S; Matsui Y; Makuuchi M
    Transplant Proc; 2007 Jun; 39(5):1540-3. PubMed ID: 17580184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?
    Schmeding M; Kienlein S; Röcken C; Neuhaus R; Neuhaus P; Heidenhain C; Neumann UP
    Transpl Immunol; 2010 Aug; 23(4):156-60. PubMed ID: 20558292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanylate-binding protein 2 mRNA in peripheral blood leukocytes of liver transplant recipients as a marker for acute cellular rejection.
    Kobayashi S; Nagano H; Marubashi S; Hama N; Eguchi TA; Takeda Y; Tanemura M; Doki Y; Mori M
    Transpl Int; 2010 Apr; 23(4):390-6. PubMed ID: 19912588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients.
    Gehrau R; Maluf D; Archer K; Stravitz R; Suh J; Le N; Mas V
    Mol Med; 2011; 17(7-8):824-33. PubMed ID: 21519635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation.
    MacQuillan GC; de Boer WB; Allan JE; Platten MA; Reed WD; Jeffrey GP
    Clin Transplant; 2010; 24(2):252-8. PubMed ID: 19712085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
    Hashimoto K; Miller C; Hirose K; Diago T; Aucejo F; Quintini C; Eghtesad B; Corey R; Yerian L; Lopez R; Zein N; Fung J
    Clin Transplant; 2010; 24(5):701-8. PubMed ID: 20047619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C.
    Grassi A; Quarneti C; Ravaioli M; Bianchini F; Susca M; D'Errico A; Piscaglia F; Tamè MR; Andreone P; Grazi G; Galli S; Zauli D; Pinna AD; Bianchi FB; Ballardini G
    Liver Transpl; 2006 Nov; 12(11):1673-81. PubMed ID: 17031825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome at the time of hepatitis C virus recurrence may predict the severity of fibrosis progression after liver transplantation.
    Mas V; Maluf D; Archer KJ; Potter A; Suh J; Gehrau R; Descalzi V; Villamil F
    Liver Transpl; 2011 Jul; 17(7):824-35. PubMed ID: 21618696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
    Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation.
    Asaoka T; Marubashi S; Kobayashi S; Hama N; Eguchi H; Takeda Y; Tanemura M; Wada H; Takemasa I; Takahashi H; Ruiz P; Doki Y; Mori M; Nagano H
    J Surg Res; 2012 Dec; 178(2):1003-14. PubMed ID: 22889476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.